VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer. He succeeds ...
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA"), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief ...
Remember when AI assistants first became popular and most people used them for simple tasks like rewriting emails or ...
Eugenio Battaglia is a biotechnology researcher who has worked with the European Union to develop frameworks for responsible ...
I thought I was going to Panama to play Central America's highest golf course. Instead I discovered one of the last great ...
DOOM maker id Software has rebutted claims it’s being scaled down to “support studio” size. In a statement, it said that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results